Navigation Links
Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía
Date:9/2/2014

entó del 60,6 al 67,5 % en el mismo período, ya que pocos pacientes recibieron un VKA (57,5 a 41,1 %).

Los 12.448 pacientes prospectivos con al menos un año de datos de seguimiento tras el diagnóstico de AF en el momento del análisis se incluyeron en tres pósters presentados en el ESC Congress 2014.

Sólo el 25 % de los pacientes tratados con VKAs logran un adecuado control anticoagulación[3]  

  • Las directrices del ESC sugieren que los pacientes se pueden considerar bien tratados en la terapia VKA si invierten al menos el 70% de su tiempo en el abanico terapéutico, por ejemplo, con una media internacional normalizada (INR) de 2,0-3,0[4].
  • El requisito para los pacientes con VKA de someterse a un control de rutina y ajuste de dosis, además de la dificultad para mantener el efecto anticoagulante óptimo, son de una consideración importante cuando se elige entre terapias anticoagulantes. Las NOACs se dan en dosis fijas y ejercen un efecto anticoagulante predecible sin necesidad de control.
  • De los 5.107 pacientes de GARFIELD-AF tratados con VKAs y con registros INR disponibles, solo el 25% (n=1.301) cumplen con el estándar del 70% para el control VKA (con el control INR evaluado como frecuencia en la gama (FIR)).
  • Los pacientes cuyo control VKA fue sub-óptimo fueron mucho más propensos a padecer apoplejía, un evento hemorrágico importante, y fallecimiento.

2 de cada 5 pacientes de bajo riesgo reciben anticoagulación frente a las recomendaciones de las directrices[5]  

  • Los pacientes que padecen AF y con una puntuación de riesgo CHA2DS2-VASc[6] de 0 se consideran por las directrices ESC co
    '/>"/>

SOURCE GARFIELD-AF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
2. Enciclopedia online gratuita sobre el cáncer para la diagnosis y tratamiento del cáncer
3. Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
4. One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines
5. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
6. Kalila Medical Announces CE Mark Approval For The Vado Steerable Sheath Used During Atrial Fibrillation Procedures
7. Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
8. Global Atrial Fibrillation Market Report 2013 - 2019
9. The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market
10. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
11. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Governor Tom Wolf announced today that ... markets implants in the spine and trauma markets, will establish ... Northampton County to serve as its ... 25 new, full-time jobs. "Tyber Medical,s decision ... more than two dozen, high-paying jobs is great news for ...
(Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
(Date:8/4/2015)... -- The Pittsburgh Life Sciences Greenhouse (PLSG), the region,s only ... of its portfolio companies, Medrobotics Corporation, has received FDA ... System in the U.S.  "I couldn,t ... John W. Manzetti , president and CEO of ... spinning out of The Robotics Institute at Carnegie Mellon ...
Breaking Medicine Technology:Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 2Pittsburgh Life Sciences Greenhouse Portfolio Client Medrobotics Receives FDA Market Clearance 3
... and NEW YORK, Nov. 9, 2010 ... ACCP ), a biopharmaceutical company leveraging its proprietary drug-delivery ... care and diabetes, announced today that its Chairman, Steven Rouhandeh, ... Investors Conference on Friday, November 12, 2010, at 1:00 pm ...
... Nov. 9, 2010 MonoSol Rx, the ... delivery company specializing in proprietary pharmaceutical film products, today ... 7,824,588 from the United States Patent and Trademark Office ... intellectual property protection for the Company,s film products and ...
Cached Medicine Technology:Access Pharmaceuticals to Present at LifeTech Capital Miami Medical Investors Conference on November 12th 2MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films 2MonoSol Rx Issued Strategic U.S. Patent Governing the Manufacturing of Pharmaceutical Films 3
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... information, checking with “Dr. Google” before calling a physician. In an effort to ... the first health care provider in Pennsylvania to publicly share patient satisfaction ratings ...
(Date:8/4/2015)... ... 04, 2015 , ... NutraScience Labs , a world-class ... joined over 200 other Long Island-based corporations as participants in the 10th annual ... Jones Beach State Park in Wantagh, New York. , According to Mindy Davidson, ...
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... ... August 04, 2015 , ... Montclair State University and Atlantic Health ... of its kind in New Jersey, which starting this Fall will help prepare those ... School partnered with Atlantic Health System, one of the largest health care organizations in ...
(Date:8/4/2015)... ... August 04, 2015 , ... Providigm, LLC, a developer of ... announced details of the Advanced level of their national accreditation for Quality Assurance ... Accreditation program , introduced in 2013, is based on standards for excellence in ...
Breaking Medicine News(10 mins):Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3
... as sprain or muscle rupture raised venous thrombosis odds, study ... injures -- including ankle sprains and muscle ruptures -- ... or lungs, suggests a study by researchers in the Netherlands. ... treatments such as surgery, a plaster cast, and extended bed ...
... of the largest studies yet of Alzheimers disease ... researchers at Mayo Clinic Jacksonville have found strong ... risk factor APOE4 influence who is at risk ... , Studying 25 multigenerational families of individuals diagnosed ...
... a human-pathogenic virus which belongs to the herpes virus ... infestation rate of more than 90 %, EBV is ... genome consists of double-stranded DNA, and it is one ... humans under certain circumstances. EBV-associated cancers include lymphomas (cancer ...
... are sometimes unable to carry out their relatives wish to ... making a gift of life and protecting the body of ... Advanced Nursing. , Researchers from the University of Southampton, UK, ... their relatives bodies be used for organ donations about their ...
... the increase , , THURSDAY, Jan. 17 (HealthDay News) -- ... in three decades, according to a new report released ... Rachel Jones, senior research associate at the Guttmacher Institute, ... findings will be published in the March issue of ...
... ... - Multi-year collaboration for NLP-based literature search and ... Linguamatics,Ltd, the leader in natural language processing (NLP) for life ... an affiliate of the Medical Knowledge Group (MKG), announce a,multi-year ...
Cached Medicine News:Health News:Minor Leg Injuries Might Boost Blood Clot Risk 2Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 2Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 3Health News:Evidence found for genes that affect risk of developing Alzheimer's disease 4Health News:A tricky tumor virus 2Health News:Relatives who decline organ donations face conflict and guilt 2Health News:Relatives who decline organ donations face conflict and guilt 3Health News:U.S. Abortion Rate Falls to Lowest Level in Decades 2Health News:U.S. Abortion Rate Falls to Lowest Level in Decades 3Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 2Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 3Health News:Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management 4
... Healon is a sterile, nonpyrogenic, viscoelastic ... high molecular weight fraction of sodium ... sodium hyaluronate dissolved in physiological sodium ... high molecular weight polymer is made ...
... fiscal year 2004, Biomet plans to ... to the global market, enhancing visualization ... Acumen technology was developed in conjunction ... based in Hollywood, Florida. Procedure-specific software ...
... response and eye movement is an important ... because eye movements and pupil responses are ... visual neuronal centers and pathways that are ... Analyzer (VPA) provides pre-programmed visual stimuli and ...
From the initial viewing screen through the completion of the exam the ADIS-9000 has been designed for ease of use and intuitive operation. The built-in software simplifies patient reporting, image s...
Medicine Products: